Rosalind Advisors’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
BBA
ACA
Rosalind Advisors's TARA Position: Q3 2026 in Review
Rosalind Advisors opened a new position in Protara Therapeutics (TARA) in Q3 2026: 2,400,000 shares worth $7.32M. The stake represents 2.35% of the portfolio and ranks #13 among its holdings.
119 funds tracked by Wall St. Rank hold TARA as of Q3 2026.
- Rosalind Advisors held 2,400,000 shares of Protara Therapeutics worth $7.32M as of Q3 2026.
- Protara Therapeutics was a new Rosalind Advisors position in Q3 2026.
- Protara Therapeutics made up 2.35% of Rosalind Advisors's portfolio in Q3 2026, its #13 holding.
- 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.
Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.